Acute response to cholinergic challenge predicts long-term response to galantamine treatment in patients with Alzheimer's disease

Autor: Groeneveld Gj, Baakman Ac, Broekhuizen K, Cohen A, Lemstra E, Schoonenboom N, Gerven Jv, Doeselaar Lv, Kalisvaart K, Kam, Gavan C, Camps L, Bajenaru O, Swart E, Scheltens P

Publikováno v: British Journal of Clinical Pharmacology. Wiley-Blackwell
British Journal of Clinical Pharmacology, 88(6), 2814-2829. WILEY
Baakman, A C, Gavan, C, van Doeselaar, L, de Kam, M, Broekhuizen, K, Bajenaru, O, Camps, L, Swart, E L, Kalisvaart, K, Schoonenboom, N, Lemstra, E, Scheltens, P, Cohen, A, van Gerven, J & Groeneveld, G J 2021, ' Acute response to cholinergic challenge predicts long-term response to galantamine treatment in patients with Alzheimer's disease ', British Journal of Clinical Pharmacology . https://doi.org/10.1111/bcp.15206, https://doi.org/10.1111/bcp.15206

Aims Cholinesterase inhibitors (CEIs) have been shown to improve cognitive functioning in Alzheimer's disease (AD) patients, but are associated with multiple side effects and only 20-40% of the patients clinically improve. In this study, we aimed to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef9c34848808f69e7675427390ea1695
https://pubmed.ncbi.nlm.nih.gov/34964149

Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial

Autor: Comi, G, Martinelli, V, Rodegher, M, Moiola, L, Bajenaru, O, Carra, A, Elovaara, I, Fazekas, F, Hartung, HP, Hillert, J, King, J, Komoly, S, Lubetzki, C, Montalban, X, Myhr, KM, Ravnborg, M, Rieckmann, P, Wynn, D, Young, C, Filippi, M

Publikováno v: In The Lancet 2009 374(9700):1503-1511

How satisfied are cervical dystonia patients after 3 years of botulinum toxin type A treatment? Results from a prospective, long-term observational study

Autor: Colosimo, C, Charles, D, Misra, VP, Maisonobe, P, Om, S, Abdulnayef, A, Adatepe, NU, Leite, AMA, Badarny, S, Bajenaru, O, Bares, M, Bejjani, P, Bergmans, B, Bhidayasiri, R, Bozic, H, Costa, CFE, Carlstrom, C, Castelnovo, G, Chang, MH, Chang, YY, Chung, TM, Coletti-Moja, M, Delvaux, V, Dioszhegy, P, Dogu, O, Duzynski, W, Ehler, E, Sierra, EL, Fabbrini, G, Ferreira, J, Valadas, FA, Foresti, C, Girlanda, P, Goh, KJ, Velon, GA, Grill, S, Gurevitch, T, Hadidi, M, Hamimed, MA, Hamri, A, Harrower, T, Hassin, S, Hedera, P, Hernandez, JFJG, Franco, HJ, Ho, B, Ho, SL, Hughes, A, Ilic, T, Inshasi, JS, Ip, CW, Jamieson, S, Jamora, RDG, Jech, R, Jeon, BS, Kaminska, A, Karpova, M, Khasanova, D, Kim, JM, Kim, JW, Kok, CY, Korenko, A, Korv, J, Koussa, S, Kovacs, T, Kreisler, A, Krystkowiak, P, Kumthornthip, W, Lin, CH, Lundin, F, Lus, G, Magalhaes, M, Masmoudi, AN, Mercelis, R, Misbahuddin, A, Moebius, C, Mohammadi, B, Nazem, B, Ng, K, Nurlu, G, Nyberg, J, Nyholm, D, Ochudlo, S, Otruba, P, Pfister, R, Pirtosek, Z, Pokhabov, D, Aguilar, QS, Canales, QG, Raghev, S, Rickmann, H, Romano, M, Rosales, RL, Rubanovits, I, Santilli, V, Schoels, L, Simonetta-Moreau, M, Ma, S, Sohn, YH, Soulayrol, S, Supe, I, Svetel, M, Sycha, T, Tan, EK, Timerbaeva, S, Tokcaer, AB, Trosch, R, Tugnoli, V, Tumas, V, Van der Linden, C, Vetra, A, Vial, C, Vidry, E, Williams, D, Wimalaratna, S, Yiannikas, C

Publikováno v: Journal of Neurology

Background Patients with cervical dystonia (CD) typically require regular injections of botulinum toxin to maintain symptomatic control. We aimed to document long-term patient satisfaction with CD symptom control in a large cohort of patients treated

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6cfd07e843c1dce3e176d6150aaa5a4
http://hdl.handle.net/10044/1/75815

Randomized trial of safinamide add‐on to levodopa in Parkinson's disease with motor fluctuations

Autor: Borgohain, R, Szasz, J, Stanzione, P, Meshram, C, Bhatt, M, Chirilineau, D, Stocchi, F, Lucini, V, Giuliani, R, Forrest, E, Rice, P, Anand, R, Sahadulla, M, Kardan, U, Keshava, B, Kishore, A, Kothari, S, Krishna Murthy, J, Kumar, S, Pal, P, Mehta, N, Prabhakar, S, Pradhan, S, Roy, A, Sankhla, C, Sethi, P, Shah, A, Shankar, N, Shukla, R, Sowani, A, Srinivasa, R, Varma, M, Vasudevan, D, Sreenivas, P, Velmurugendran, C, Vijayan, K, Bajenaru, O, Bulboaca, A, Campeanu, A, Chirileanu, D, Muresanu, D, Panea, C, Popescu, C, Simu, M, Ticmeanu, M, Avarello, T, Bonuccelli, U, Eleopra, R, Onofrj, M, Quatrale, R

Publikováno v: Movement Disorders

Levodopa is effective for the motor symptoms of Parkinson's disease (PD), but is associated with motor fluctuations and dyskinesia. Many patients require add-on therapy to improve motor fluctuations without exacerbating dyskinesia. The objective of t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::077fdce8b17491a5ed88be0aecff2ce3
https://doi.org/10.1002/mds.25751

Efficacy and safety of Cerebrolysin in patients with hemorrhagic stroke.

Autor: Bajenaru, O.¹ ovalbajenaru@yahoo.com, Tiu, C.¹, Moessler, H.², Antochi, F.¹, Muresanu, D.³, Popescu, B. O.¹, Novak, Philipp²

Publikováno v: Journal of Medicine & Life. Apr-Jun2010, Vol. 3 Issue 2, p137-143. 7p. 1 Diagram, 5 Charts, 4 Graphs.